144 related articles for article (PubMed ID: 34176458)
21. Synthesis of novel spirooxindole-pyrrolidines and evaluation of their cytotoxic activity.
Tumskiy RS; Burygin GL; Anis'kov AA; Klochkova IN
Pharmacol Rep; 2019 Apr; 71(2):357-360. PubMed ID: 30844686
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.
Barakat A; Islam MS; Ghawas HM; Al-Majid AM; El-Senduny FF; Badria FA; Elshaier YAMM; Ghabbour HA
Bioorg Chem; 2019 May; 86():598-608. PubMed ID: 30802707
[TBL] [Abstract][Full Text] [Related]
23. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
[TBL] [Abstract][Full Text] [Related]
24. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
[TBL] [Abstract][Full Text] [Related]
25. Organocatalytic Asymmetric Synthesis of Spiro-oxindole Piperidine Derivatives That Reduce Cancer Cell Proliferation by Inhibiting MDM2-p53 Interaction.
Yang MC; Peng C; Huang H; Yang L; He XH; Huang W; Cui HL; He G; Han B
Org Lett; 2017 Dec; 19(24):6752-6755. PubMed ID: 29210587
[TBL] [Abstract][Full Text] [Related]
26. A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
Bharkavi C; Vivek Kumar S; Ashraf Ali M; Osman H; Muthusubramanian S; Perumal S
Bioorg Med Chem; 2016 Nov; 24(22):5873-5883. PubMed ID: 27687968
[TBL] [Abstract][Full Text] [Related]
27. A Diastereoselective Synthesis of Dispiro[oxindole-cyclohexanone]pyrrolidines by 1,3-Dipolar Cycloaddition.
Anis'kov A; Klochkova I; Tumskiy R; Yegorova A
Molecules; 2017 Dec; 22(12):. PubMed ID: 29207519
[TBL] [Abstract][Full Text] [Related]
28. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
29. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of in vitro cytotoxic effects of triazol/spiroindolinequinazolinedione, triazol/indolin-3-thiosemicarbazone and triazol/thiazol-indolin-2-one conjugates.
Nazari S; Safari F; Mamaghani MB; Bazgir A
Daru; 2020 Dec; 28(2):591-601. PubMed ID: 32803690
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of new spirooxindole-pyrrolothiazole derivatives: Anti-cancer activity and molecular docking.
Lotfy G; Said MM; El Ashry ESH; El Tamany ESH; Al-Dhfyan A; Abdel Aziz YM; Barakat A
Bioorg Med Chem; 2017 Feb; 25(4):1514-1523. PubMed ID: 28126436
[TBL] [Abstract][Full Text] [Related]
32. Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification.
Hati S; Tripathy S; Dutta PK; Agarwal R; Srinivasan R; Singh A; Singh S; Sen S
Sci Rep; 2016 Aug; 6():32213. PubMed ID: 27573798
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
34. Microwave-assisted rapid synthesis of spirooxindole-pyrrolizidine analogues and their activity as anti-amyloidogenic agents.
de Silva NH; Pyreddy S; Blanch EW; Hügel HM; Maniam S
Bioorg Chem; 2021 Sep; 114():105128. PubMed ID: 34225163
[TBL] [Abstract][Full Text] [Related]
35. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
[TBL] [Abstract][Full Text] [Related]
36. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.
Kaur M; Singh P
Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310
[TBL] [Abstract][Full Text] [Related]
37. 1,3-Dipolar Cycloaddition Reactions for the Synthesis of Novel Oxindole Derivatives and Their Cytotoxic Properties.
Mali PR; Shirsat PK; Khomane N; Nayak L; Nanubolu JB; Meshram HM
ACS Comb Sci; 2017 Oct; 19(10):633-639. PubMed ID: 28816439
[TBL] [Abstract][Full Text] [Related]
38. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
39. Spiro[pyrrolidine-2,3'-oxindole] derivatives synthesized by novel regionselective 1,3-dipolar cycloadditions.
Chen G; Yang J; Gao S; He H; Li S; Di Y; Chang Y; Lu Y; Hao X
Mol Divers; 2012 Feb; 16(1):151-6. PubMed ID: 22134725
[TBL] [Abstract][Full Text] [Related]
40. Facile, regio- and diastereoselective synthesis of spiro-pyrrolidine and pyrrolizine derivatives and evaluation of their antiproliferative activities.
Almansour AI; Kumar RS; Beevi F; Shirazi AN; Osman H; Ismail R; Choon TS; Sullivan B; McCaffrey K; Nahhas A; Parang K; Ali MA
Molecules; 2014 Jul; 19(7):10033-55. PubMed ID: 25014532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
